Nouvelle déclaration d'incident
No de la demande: 2025-5609
Numéro de référence du titulaire d'homologation: 2025-CA-000420
Nom du titulaire (nom légal complet, aucune abbréviation): The Hartz Mountain Corporation
Adresse: 200 Plaza Drive, Suite 402
Ville: Secaucus
État: New Jersey
Pays: USA
Code postal /Zip: 07094
Incident chez un animal domestique
Pays: CANADA
État: QUEBEC
ARLA No d'homologation 29930 ARLA No de la demande d'homologation EPA No d'homologation.
Nom du produit: Hartz UltraGuard OneSpot Flea and Tick Cat Drops
Oui
Inconnu
Site: Animal / Usage sur un animal domestique
Non
Propriétaire de l'animal
Cat / Chat
Chartreuse
1
Femme
7.0
4.5
kg
Cutanée
>1 wk <=1 mo / > 1 sem < = 1 mois
<=30 min / <=30 min
Système
>3 days <=1 wk / >3 jours <=1 sem
Non
Non
Fully Recovered / Complètement rétabli
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
On approximately 11-Jun-2025, a 7 year old, 10 pound, neutered, female, Chartreuse cat, in unknown condition, with no known concomitant medical conditions, was administered a portion of one tube of Hartz UltraGuard OneSpot Flea and Tick Cat Drops (S Methoprene) via the topical route by the animal owner. The owner reported they did not apply the entire tube since the cat started reacting before application was complete. This was off-label use due to the low dose. Immediately post application, the cat developed application site scratching (pruritus), licking at the application site, and application site hair loss. Approximately 2 hours post application, the cat did not seem like herself and developed lethargy, decreased activity, weird looking eyes (Eye disorder - NOS), listlessness, abnormal breathing, decreased drinking, and anorexia. On 12-Jun-2025, the animal owner took the cat to a veterinarian for clinical monitoring (amount of time was not specified). No clinical treatments were performed. Approximately 4 days post application, all clinical signs resolve and the cat recovered. No further information in expected.
Assessment: This product contains s-methoprene, an insect growth regulator with a very wide margin of safety in cats following topical application. Even if it were ingested, only mild GI upset is expected. Application site reactions are possible following use of any topical product and may be related either the active or inactive ingredients. It is possible the cat did not like the sensation of the liquid product being applied to its fur/skin. This can result in behavior changes like agitation, lethargy, hiding, and shaking. Changes in breathing are not expected unless related the anxiety or agitation due to the sensation of the product being applied. Signs also tend to resolve as the product dries and not persist for 4 days. Other causes should also be considered but no apparent treatments or diagnostics were performed in this case. The information contained in this report is based on self-reported statements provided to the registrant during telephone interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.